-
Nama fraud trial set for January - 10 mins ago
-
‘Whole neighbourhood wiped out’ in Israel air strike - 15 mins ago
-
New Polls Show Donald Trump’s Chances of Winning Georgia - 18 mins ago
-
Short Amazon and Apple as they head into earnings season, say Itau BBA analysts - 21 mins ago
-
MLS awards finalists: Lionel Messi, Luis Suarez up for MVP; Wilfried Nancy to win top coach again? - 22 mins ago
-
Belfast plan to cut up to 270 jobs - 25 mins ago
-
Clippers’ treatment of Kawhi Leonard was ‘unsafe and illegal,’ trainer says - 34 mins ago
-
The Wisconsin Strategies: Harris and Trump Play the 2016 Tipping Point - 35 mins ago
-
UFC 308 predictions, odds, best bets: Max Holloway, Khamzat Chimaev prop among top picks to consider - 38 mins ago
-
Soldier B identity could be revealed, court told - 42 mins ago
Sam Altman’s OpenAI Partners With Oppenheimer’s Nuclear Research Lab
OpenAI has announced a partnership with one of the U.S.’s leading national laboratories to study how artificial intelligence can be used safely in an active lab setting.
Sam Altman’s organization will work with the Los Alamos National Laboratory, the New Mexico lab where Robert Oppenheimer and his team developed the first nuclear bomb as part of the Manhattan Project.
The partnership, announced in an OpenAI press release Wednesday, is intended to leverage generative AI to “multiply the speed and impact of science for good.”
Scientists at Los Alamos will use OpenAI’s LLMs, like ChatGPT-4o, to decide where the technology can help in their research. Tasks may include introducing foreign genetic material into a host organism and cell separation, propagating cells in vitro.
“This partnership follows a long tradition of the U.S. public sector, and in particular the national labs, working with the U.S. private sector to ensure advances in innovation translate to advancements in essential areas like health care and bioscience,” the press release states.
Los Alamos is one of the 16 research and development laboratories within the U.S. Department of Energy. While best known as the birthplace of the atomic bomb, Los the lab today focuses on everything from national security, nuclear fusion, renewable energy, medicine and nanotechnology.
The partnership comes in the wake of an executive order from the White House last year that pushes for national labs to evaluate the capabilities of using AI within their biological research.
OpenAI’s technology has already been used by other leaders in bioscience. Moderna, the mRNA pioneer behind one of the Covid vaccines, is using OpenAI tools to augment clinical trial developments by adding an assistant that will analyze large data sets.
Color Health, which focuses on early cancer detection and comprehensive management, has also built a new copilot using ChatGPT-4o. The AI helps healthcare providers make evidence-based decisions about cancer screening and treatment.
“As a private company dedicated to serving the public interest, we’re thrilled to announce a first-of-its-kind partnership with Los Alamos National Laboratory to study bioscience capabilities,” said Mira Murati, OpenAI’s chief technology officer. “This partnership marks a natural progression in our mission, advancing scientific research, while also understanding and mitigating risks.”
Do you have a story we should be covering? Do you have any questions about Sam Altman and OpenAI? Contact LiveNews@newsweek.com.
Uncommon Knowledge
Newsweek is committed to challenging conventional wisdom and finding connections in the search for common ground.
Newsweek is committed to challenging conventional wisdom and finding connections in the search for common ground.
Source link